Summary of Classification and Labelling
General Information
EC / List no.
|
Name |
CAS Number
|
|---|---|---|
| 251-406-1 | Quadrosilan | 33204-76-1 |
Notified classification and labelling according to CLP criteria
| Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives
|
Additional Notified Information
|
Number of Notifiers
|
Joint Entries
|
||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
| Repr. 1B | H360F | H360F |
GHS08 Dgr |
31 | View details | ||||||
| STOT RE 1 | H372 (adrenal glands,...) | H372 | |||||||||
| Aquatic Chronic 4 | H413 | H413 | |||||||||
| Repr. 1B | H360 (oral) | H360 |
GHS08 Dgr |
22 | View details | ||||||
| STOT RE 1 | H372 (adrenal gland; ...) (oral) | H372 | |||||||||
| Aquatic Chronic 4 | H413 | H413 | |||||||||
| Repr. 1B | H360 (oral) | H360 |
GHS08 Dgr |
State/Form
|
20 | View details | |||||
| Repr. 1B | H360 | H360 | |||||||||
| STOT SE 1 | H371 (adrenal glands) | H371 | |||||||||
| STOT SE 1 | H371 (Adrenal glands) | H371 | |||||||||
| Aquatic Chronic 4 | H413 | H413 | |||||||||
| Repr. 1B | H360 |
GHS08 Dgr |
2 | View details | |||||||
| H360F | |||||||||||
| STOT RE 1 | H372 (other:Adrenal g...) (oral) | H372 | |||||||||
| Aquatic Chronic 4 | H413 | H413 | |||||||||
| Repr. 1B | H360F | H360F |
GHS08 Dgr |
State/Form
|
1 | View details | |||||
| Aquatic Chronic 4 | H413 | H413 | |||||||||
Number of Aggregated Notifications: 5